Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
YAP (Yes-associated protein) is a transcription co-activator in the Hippo tumour suppressor pathway and controls cell growth, tissue homeostasis and organ size. YAP is inhibited by the kinase Lats, which phosphorylates YAP to induce its cytoplasmic localization and proteasomal degradation. YAP induces gene expression by binding to the TEAD family transcription factors. Dysregulation of the Hippo-YAP pathway is frequently observed in human cancers. Here we show that cellular energy stress induces YAP phosphorylation, in part due to AMPK-dependent Lats activation, thereby inhibiting YAP activity. Moreover, AMPK directly phosphorylates YAP Ser 94, a residue essential for the interaction with TEAD, thus disrupting the YAP-TEAD interaction. AMPK-induced YAP inhibition can suppress oncogenic transformation of Lats-null cells with high YAP activity. Our study establishes a molecular mechanism and functional significance of AMPK in linking cellular energy status to the Hippo-YAP pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and the direct phosphorylation of YAP on Ser61/94, which is key for the interaction between Yap and Teads (100, 145).”
From The Hippo signal transduction network for exercise physiologists (2016) · cites this paper as [100]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Both glucose starvation (36, 100, 145) and AMPK activators (26, 100, 145) inhibit Yap in different cell types.”
From The Hippo signal transduction network for exercise physiologists (2016) · cites this paper as [100]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Endurance exercise-associated signals linked to YAP/TAZ”
From The Hippo signal transduction network for exercise physiologists (2016) · cites this paper as Mo et al Nature Cell Biol (2015)
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · cited 1×
“…the AMPK-DN increased reporter activity, consistent with the notion that AMPK-DN interferes with endogenous AMPK function in a dominant-negative fashion ‥ Metformin, a widely prescribed drug for type II diabetes 35 , activates AMPK, inhibits cell growth and reduces tumor incidence 36, 37 .”
AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
Kim, J., Kundu, M., Viollet, B., & Guan, K.-L. (2011) · Nature Cell Biology · doi:10.1038/ncb2152 · Cited by 7,227
Self-citationRole of YAP/TAZ in mechanotransduction
Dupont, S., Morsut, L., Aragona, M., Enzo, E., Giulitti, S., Cordenonsi, M., Zanconato, F., Le Digabel, J., Forcato, M., Bicciato, S., et al. (2011) · Nature · doi:10.1038/nature10137 · Cited by 5,979
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914
Self-citationZhao, B., Wei, X., Li, W., Udan, R. S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L., et al. (2007) · Genes & Development · doi:10.1101/gad.1602907 · Cited by 3,092
Self-citationTEAD mediates YAP-dependent gene induction and growth control
Zhao, B., Ye, X., Yu, J., Li, L., Li, W., Li, S., Yu, J., Lin, J. D., Wang, C.-Y., Chinnaiyan, A. M., et al. (2008) · Genes & Development · doi:10.1101/gad.1664408 · Cited by 2,498
Self-citationMetformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388
Elucidation of a universal size-control mechanism in Drosophila and mammals
Dong, J., Feldmann, G., Huang, J., Wu, S., Zhang, N., Comerford, S. A., Gayyed, M. F., Anders, R. A., Maitra, A., & Pan, D. (2007) · Cell · doi:10.1016/j.cell.2007.07.019 · Cited by 2,370
The Hippo Signaling Pathway in Development and Cancer
Pan, D. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.09.011 · Cited by 2,269
Cited by
Items 201–300 of 593
Targeting the Hippo signalling pathway for cancer treatment
Nakatani, K., Maehama, T., Nishio, M., Goto, H., Kato, W., Omori, H., Miyachi, Y., Togashi, H., Shimono, Y., & Suzuki, A. (2016) · The Journal of Biochemistry · doi:10.1093/jb/mvw074 · Cited by 52
Saikawa, S., Kaji, K., Nishimura, N., Seki, K., Sato, S., Nakanishi, K., Kitagawa, K., Kawaratani, H., Kitade, M., Moriya, K., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.07.021 · Cited by 51
Yap regulates skeletal muscle fatty acid oxidation and adiposity in metabolic disease
Watt, K. I., Henstridge, D. C., Ziemann, M., Sim, C. B., Montgomery, M. K., Samocha‐Bonet, D., Parker, B. L., Dodd, G. T., Bond, S. T., Salmi, T. M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23240-7 · Cited by 51
Metformin Syncs CeO 2 to Recover Intra‐ and Extra‐Cellular ROS Homeostasis in Diabetic Wound Healing
Li, M., Dong, Y., Shang, Y., Liu, J., Wang, Y., Zhang, D., Zhang, L., Han, C., Zhang, Y., Shen, K., et al. (2024) · Small · doi:10.1002/smll.202407802 · Cited by 50
Park, G.-S., Oh, H., Kim, M., Kim, T., Johnson, R. L., Irvine, K. D., & Lim, D.-S. (2016) · Oncotarget · doi:10.18632/oncotarget.8211 · Cited by 46
Self-citationPP2Ac/STRN4 negatively regulates STING-type I IFN signaling in tumor-associated macrophages
Ho, W. S., Mondal, I., Xu, B., Das, O., Sun, R., Chiou, P., Cai, X., Tahmasebinia, F., McFadden, E., Wu, C. Y.-J., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci162139 · Cited by 50
Self-citationA global phosphosite-correlated network map of Thousand And One Kinase 1 (TAOK1)
Priyanka, P., Gopalakrishnan, A. P., Nisar, M., Shivamurthy, P. B., George, M., John, L., Sanjeev, D., Yandigeri, T., Thomas, S. D., Rafi, A., et al. (2024) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2024.106558 · Cited by 50
The Hippo signal transduction network for exercise physiologists
Gabriel, B. M., Hamilton, D. L., Tremblay, A. M., & Wackerhage, H. (2016) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01076.2015 · Cited by 48
Endothelial Cell Mechano-Metabolomic Coupling to Disease States in the Lung Microvasculature
Wu, D., & Birukov, K. G. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00172 · Cited by 48
Atheroprotective effects of methotrexate via the inhibition of YAP/TAZ under disturbed flow
Liu, D., Lv, H., Liu, Q., Sun, Y., Hou, S., Zhang, L., Yang, M., Han, B., wang, G., Wang, X., et al. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-02135-8 · Cited by 48
The regulatory networks of the Hippo signaling pathway in cancer development
Wang, M., Dai, M., Wang, D., Xiong, W., Zeng, Z., & Guo, C. J. (2021) · Journal of Cancer · doi:10.7150/jca.62402 · Cited by 48
The mevalonate coordinates energy input and cell proliferation
Gong, L., Xiao, Y., Xia, F., Wu, P., Zhao, T., Xie, S., Wang, R., Wen, Q., Zhou, W., Xu, H., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1544-y · Cited by 48
Emerging role of Hippo signalling pathway in bladder cancer
Xia, J., Zeng, M., Zhu, H., Chen, X., Weng, Z., & Li, S. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13293 · Cited by 47
IQGAP1 Binds to Yes-associated Protein (YAP) and Modulates Its Transcriptional Activity
Sayedyahossein, S., Li, Z., Hedman, A. C., Morgan, C. J., & Sacks, D. B. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.732529 · Cited by 47
Dapagliflozin delays renal fibrosis in diabetic kidney disease by inhibiting YAP/TAZ activation
Feng, L., Chen, Y., Li, N., Yang, X., Zhou, L., Li, H., Wang, T., Xie, M., & Liu, H. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121671 · Cited by 46
Shimada, H., Abe, S., Kohno, T., Satohisa, S., Konno, T., Takahashi, S., Hatakeyama, T., Arimoto, C., Kakuki, T., Kaneko, Y., et al. (2017) · Scientific Reports · doi:10.1038/srep37049 · Cited by 46
Sun, L., Yang, X., Huang, X., Yao, Y., Wei, X., Yang, S., Zhou, D., Zhang, W., Long, Z., Xu, X., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-1517 · Cited by 46
The role of the Hippo pathway in autophagy in the heart
Maejima, Y., Zablocki, D., Nah, J., & Sadoshima, J. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac014 · Cited by 46
Stimulation of ovarian follicle growth after AMPK inhibition
Lu, X., Guo, S., Cheng, Y., Kim, J.-H., Feng, Y., & Feng, Y. (2017) · Reproduction · doi:10.1530/rep-16-0577 · Cited by 46
Progress and challenges in Mesothelioma: From bench to bedside
Blyth, K. G., & Murphy, D. J. (2017) · Respiratory Medicine · doi:10.1016/j.rmed.2017.11.015 · Cited by 46
Somatic Hypermutation of the YAP Oncogene in a Human Cutaneous Melanoma
Zhang, X., Tang, J., Vergara, I. A., Zhang, Y., Szeto, P., Yang, L., Mintoff, C., Colebatch, A. J., McIntosh, L., Mitchell, K. A., et al. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0407 · Cited by 45
Context-dependent transcriptional regulations of YAP/TAZ in stem cell and differentiation
Luo, J., & Li, P. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02686-y · Cited by 44
The Hippo pathway, p53 and cholesterol
Aylon, Y., & Oren, M. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1207840 · Cited by 44
The genetic landscape and possible therapeutics of neurofibromatosis type 2
Ghalavand, M. A., Asghari, A., Farhadi, M. R., Taghizadeh‐Hesary, F., Garshasbi, M., & Falah, M. (2023) · Cancer Cell International · doi:10.1186/s12935-023-02940-8 · Cited by 43
Bai, H., Zhu, Q., Surcel, A., Luo, T., Ren, Y., Guan, B., Liu, Y., Wu, N., Joseph, N. E., Wang, T., et al. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00027.2016 · Cited by 43
The transcriptional co-activator YAP: A new player in head and neck cancer
Segrelles, C., Paramio, J. M., & Lorz, C. (2018) · Oral Oncology · doi:10.1016/j.oraloncology.2018.08.020 · Cited by 43
Li, M., Rao, X., Cui, Y., Zhang, L., Li, X., Wang, B., Zheng, Y., Teng, L., Zhou, T., & Zhuo, W. (2021) · Oncogene · doi:10.1038/s41388-021-02119-3 · Cited by 43
Metabolic Determinants of Cardiomyocyte Proliferation
Mohamed, T., Abouleisa, R., & Hill, B. G. (2022) · Stem Cells · doi:10.1093/stmcls/sxac016 · Cited by 43
Regulation of Hippo signaling pathway in cancer: A MicroRNA perspective
Samji, P., Rajendran, M. K., Warrier, V. P., Ganesh, A., & Karunagaran, D. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109858 · Cited by 42
Jin, D., Guo, J., Wang, D., Wu, Y., Wang, X., Gao, Y., Shao, C., Xu, X., & Tan, S. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.10.044 · Cited by 41
RetractedContext-dependent transcriptional regulations of YAP/TAZ in cancer
Guo, Y., Luo, J., Zou, H., Liu, C., Deng, L., & Li, P. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.12.019 · Cited by 41
YAP ping about and not forgetting TAZ
Callus, B. A., Finch‐Edmondson, M., Fletcher, S., & Wilton, S. D. (2019) · FEBS Letters · doi:10.1002/1873-3468.13318 · Cited by 39
Zhang, S., Sheng, H., Zhang, X., Qi, Q., Chan, C. B., Li, L., Shan, C., & Ye, K. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1452-1 · Cited by 39
Zhuang, Q., Li, F., Liu, J., Wang, H., Tian, Y., Zhang, Z., Wang, F., Zhao, Z., Chen, J., & Wu, H. (2020) · Laboratory Investigation · doi:10.1038/s41374-020-00503-3 · Cited by 39
Nguyen, Q. P., Anders, R. A., Alpini, G. D., & Bai, H. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2015.05.011 · Cited by 39
The role of extracellular biophysical cues in modulating the Hippo-YAP pathway
Mo, J. (2017) · BMB Reports · doi:10.5483/bmbrep.2017.50.2.199 · Cited by 39
Self-citationLATS kinase–mediated CTCF phosphorylation and selective loss of genomic binding
Luo, H., Yu, Q., Liu, Y., Tang, M., Liang, M., Zhang, D., Xiao, T. S., Wu, L., Tan, M., Ruan, Y., et al. (2020) · Science Advances · doi:10.1126/sciadv.aaw4651 · Cited by 39
Targeting AMPK Signaling in the Liver: Implications for Obesity and Type 2 Diabetes Mellitus
Liu, Y., Wang, D., & Yang, L. (2022) · Current Drug Targets · doi:10.2174/1389450123666220429082702 · Cited by 38
Song, X., Tsakiridis, E. E., Steinberg, G. R., & Pei, Y. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109704 · Cited by 39
Regulation and role of CAMKK2 in prostate cancer
Pulliam, T. L., Goli, P., Awad, D., Lin, C., Wilkenfeld, S. R., & Frigo, D. E. (2022) · Nature Reviews Urology · doi:10.1038/s41585-022-00588-z · Cited by 38
Gu, Y., Wang, Y., Sha, Z., He, C., Zhu, Y., Li, J., Yu, A., Zhong, Z., Wang, X., Sun, Y., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111296 · Cited by 38
The mitochondrial deoxyguanosine kinase is required for cancer cell stemness in lung adenocarcinoma
Lin, S., Huang, C., Sun, J., Bollt, O., Wang, X., Martine, E., Kang, J., Taylor, M. D., Fang, B., Singh, P. K., et al. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201910849 · Cited by 38
Zhang, S., Guo, M., Jiang, X., Tang, L., Wu, T., Bi, G., Yang, X., Fan, S., & Bi, H. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106666 · Cited by 37
Mitochondrial stress activates YAP/TAZ through RhoA oxidation to promote liver injury
Kwon, A., Lee, N. Y., Yu, J.-H., Choi, M. G., Park, J., & Koo, J. H. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06448-5 · Cited by 37
Nuclear phosphoinositide signaling promotes YAP/TAZ-TEAD transcriptional activity in breast cancer
Jung, O., Baek, M.-J., Wooldrik, C., Johnson, K. R., Fisher, K. W., Lou, J., Ricks, T. J., Wen, T., Best, M. D., Cryns, V. L., et al. (2024) · The EMBO Journal · doi:10.1038/s44318-024-00085-6 · Cited by 37
MK5 Regulates YAP Stability and Is a Molecular Target in YAP-Driven Cancers
Seo, J., Kim, M. H., Hong, H., Cho, H., Park, S., Kim, S. K., & Kim, J. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-1339 · Cited by 37
Self-citationWang, Q., Pan, L., Wang, T., Zheng, Q., Li, Y., Leng, S. X., Meng, X., Wang, B., Xie, J., & Zhang, H. (2020) · Cancer Medicine · doi:10.1002/cam4.3024 · Cited by 37
G protein‐coupled receptors can control the Hippo/YAP pathway through Gq signaling
Zindel, D., Mensat, P., Vol, C., Homayed, Z., Charrier‐Savournin, F., Trinquet, E., Banères, J., Pin, J., Pannequin, J., Roux, T., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202002159r · Cited by 37
Tong, G., Chen, X., Lee, J., Fan, J., Li, S., Zhu, K., Hu, Z., Mei, L., Sui, Y., Dong, Y., et al. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106139 · Cited by 37
Chen, X., Wang, H., Wu, C. F., Li, X., Huang, X., Ren, Y., Pu, Q., Cao, Z., Tang, X., & Ding, B. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103038 · Cited by 36
Dai, J., Wang, Y., Chen, C., Tsai, I., Chao, Y., & Lin, C. (2022) · Advanced Science · doi:10.1002/advs.202103687 · Cited by 36
Posttranslational modifications of YAP/TAZ: molecular mechanisms and therapeutic opportunities
Zhang, Z., He, P., Li, Y., Gong, J., Qin, R., & Min, W. Z. (2025) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-025-00760-4 · Cited by 35
D’Angelo, E., Lindoso, R. S., Sensi, F., Pucciarelli, S., Bussolati, B., Agostini, M., & Collino, F. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01122 · Cited by 36
The Hippo–YAP Signaling as Guardian in the Pool of Intestinal Stem Cells
Seo, Y., Park, S., Kim, H., & Nam, J. (2020) · Biomedicines · doi:10.3390/biomedicines8120560 · Cited by 35
Moon, J., Ediriweera, M. K., Ryu, J., Kim, H. J., & Cho, S. K. (2021) · Oncology Reports · doi:10.3892/or.2021.7924 · Cited by 35
Inhibitors Targeting YAP in Gastric Cancer: Current Status and Future Perspectives
Yong, J., Li, Y., Lin, S., Wang, Z., & Xu, Y. H. (2021) · Drug Design Development and Therapy · doi:10.2147/dddt.s308377 · Cited by 35
Rozengurt, E., & Eibl, G. (2021) · Cancers · doi:10.3390/cancers13205126 · Cited by 30
Regulation of Hippo signaling by metabolic pathways in cancer
Lee, U., Cho, E.-Y., & Jho, E. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.119201 · Cited by 35
Greer, Y. E., Hernandez, L. F., Fennell, E. M. J., Kundu, M., Voeller, D. M., Chari, R., Gilbert, S. F., Gilbert, T. S. K., Ratnayake, S., Tang, B., et al. (2022) · Cancer Research Communications · doi:10.1158/2767-9764.crc-22-0142 · Cited by 35
TNS1: Emerging Insights into Its Domain Function, Biological Roles, and Tumors
Wang, Z., Ye, J., Dong, F., Cao, L., Wang, M., & Sun, G. (2022) · Biology · doi:10.3390/biology11111571 · Cited by 35
The potential role of YAP in Axl-mediated resistance to EGFR tyrosine kinase inhibitors.
Saab, S., Chang, O. S.-S., Nagaoka, K., Hung, M., & Yamaguchi, H. (2019) · PubMed · Cited by 35
MARK2/MARK3 Kinases Are Catalytic Codependencies of YAP/TAZ in Human Cancer
Klingbeil, O., Skopelitis, D. S., Tonelli, C., Yoshimoto, T., Alpsoy, A., Panepinto, M. C., Minicozzi, F., Merrill, J. R., Cafiero, A. M., Aggarwal, D., et al. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-23-1529 · Cited by 34
Development and Therapeutic Potential of NUAKs Inhibitors
Faisal, M., Kim, J. H., Yoo, K. H., Roh, E. J., Hong, S. S., & Lee, S. H. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00533 · Cited by 34
Nuclear Import and Export of YAP and TAZ
Kofler, M., & Kapùs, A. (2023) · Cancers · doi:10.3390/cancers15204956 · Cited by 34
Zhong, S., Guo, Q., Chen, X., Luo, X., Long, Y., Chong, T., Ye, M., He, H., Lu, A., Ao, K., et al. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.87203 · Cited by 34
Role of CTGF in Sensitivity to Hyperthermia in Ovarian and Uterine Cancers
Hatakeyama, H., Wu, S. Y., Lyons, Y. A., Pradeep, S., Wang, W., Huang, Q., Court, K. A., Liu, T., Nie, S., Rodriguez‐Aguayo, C., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.10.020 · Cited by 34
Kohno, T., Konno, T., & Kojima, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143555 · Cited by 33
The Hippo Signaling Pathway: The Trader of Tumor Microenvironment
Yang, D., Zhang, N., Li, M., Hong, T., Meng, W., & Ouyang, T. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.772134 · Cited by 33
Mst1/2 Kinases Modulate Glucose Uptake for Osteoblast Differentiation and Bone Formation
Li, W., Deng, Y., Feng, B., & Mak, K. K. (2018) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3413 · Cited by 33
Regulation and functions of the Hippo pathway in stemness and differentiation
Cao, X., Wang, C., Liu, J., & Zhao, B. (2020) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmaa048 · Cited by 32
YAP and TAZ Mediators at the Crossroad between Metabolic and Cellular Reprogramming
Benedetto, G. D., Parisi, S., Russo, T., & Passaro, F. (2021) · Metabolites · doi:10.3390/metabo11030154 · Cited by 32
Chen, Z., Li, Y., He, K., Jianguo, Y., Deng, Q., Chen, Y., & Fu, Z. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02915-7 · Cited by 32
A two-way street - cellular metabolism and myofibroblast contraction
Noom, A., Sawitzki, B., Knaus, P., & Duda, G. N. (2024) · npj Regenerative Medicine · doi:10.1038/s41536-024-00359-x · Cited by 31
The Search for Disease-Modifying Therapies in Pulmonary Hypertension
Woodcock, C.-S. C., & Chan, S. Y. (2019) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248419829172 · Cited by 31
Serine Metabolism Regulates YAP Activity Through USP7 in Colon Cancer
Zhao, X., Fu, J., Hu, B., Chen, L., Wang, J., Fang, J., Ge, C., Lin, H., Pan, K., Fu, L., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.639111 · Cited by 31
Zhou, J., Sun, C., Yang, L., Wang, J., Jn‐Simon, N., Zhou, C., Bryant, A. J., Cao, Q., Li, C., Petersen, B. E., et al. (2022) · The FASEB Journal · doi:10.1096/fj.202101686r · Cited by 31
Hippo Signaling Pathway as a Central Mediator of Receptors Tyrosine Kinases (RTKs) in Tumorigenesis
Azad, T., Rezaei, R., Surendran, A., Singaravelu, R., Boulton, S., Dave, J., Bell, J. C., & Ilkow, C. S. (2020) · Cancers · doi:10.3390/cancers12082042 · Cited by 30
Chang, J., Go, S., Gilglioni, E. H., Duijst, S., Panneman, D. M., Rodenburg, R. J., Li, H. L., Huang, H.-L., Levin, L. R., Buck, J., et al. (2021) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2020.148367 · Cited by 30
Zhou, R., Wu, Q., Wang, M., Irani, S., Li, X., Zhang, Q. Y., Meng, F., Liu, S., Zhang, F., Wu, L., et al. (2021) · PLoS Biology · doi:10.1371/journal.pbio.3001122 · Cited by 30
Chen, Y.-C., Chien, C., Hsu, C., Lee, C.-H., Chou, Y., Shiah, S., Liu, S.-Y., Yen, C., Hsieh, A. C.-T., Wabitsch, M., et al. (2021) · PubMed · Cited by 30
Metabo-reciprocity in cell mechanics: feeling the demands/feeding the demand
Torrino, S., & Bertero, T. (2022) · Trends in Cell Biology · doi:10.1016/j.tcb.2022.01.013 · Cited by 30
Corremans, R., Neven, E., Maudsley, S. R., Leysen, H., Broe, M. E. D., D’Haese, P. C., Vervaet, B. A., & Verhulst, A. (2022) · Kidney International · doi:10.1016/j.kint.2022.01.037 · Cited by 30
Integrin‐FAK‐CDC42‐PP1A signaling gnaws at YAP/TAZ activity to control incisor stem cells
Hicks‐Berthet, J., & Varelas, X. (2017) · BioEssays · doi:10.1002/bies.201700116 · Cited by 31
Zhang, Q., Li, W., Zhu, Y., Wang, Q., Zhai, C., Shi, W., Feng, W., Wang, J., Yan, X., Chai, L., et al. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04131-3 · Cited by 30
Chen, H., Li, Q., Nirala, N. K., & Ip, Y. T. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.03.021 · Cited by 29
The Hippo pathway noncanonically drives autophagy and cell survival in response to energy stress
Seo, G., Yu, C., Han, H., Li, X., Kattan, R. E., An, J., Kizhedathu, A., Yang, B., Luo, A., Buckle, A. L., et al. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.07.019 · Cited by 29
Salminen, A. (2023) · Biogerontology · doi:10.1007/s10522-023-10072-9 · Cited by 30
Abbassi, L., Malki, S., Cockburn, K., Macaulay, A. D., Robert, C., Rossant, J., & Clarke, H. J. (2016) · Biology of Reproduction · doi:10.1095/biolreprod.115.137968 · Cited by 29
Menini, S., Iacobini, C., de Latouliere, L., Manni, I., Vitale, M., Pilozzi, E., Pesce, C. M., Cappello, P., Novelli, F., Piaggio, G., et al. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01665-0 · Cited by 28
Targeting FLT3-TAZ signaling to suppress drug resistance in blast phase chronic myeloid leukemia
Shin, J. E., Kim, S., Kong, M., Kim, H.-R., Yoon, S., Kee, K., Kim, J. A., Kim, D. H., Park, S. Y., Park, J. H., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01837-4 · Cited by 28
Self-citationde León, A. V., Jahnes, B. C., Otero-Bravo, A., & Sabree, Z. L. (2021) · mSystems · doi:10.1128/msystems.00802-21 · Cited by 28
Salek, F., Guest, A., Johnson, C., Kastelic, J. P., & Thundathil, J. C. (2025) · Animals · doi:10.3390/ani15030344 · Cited by 27
Tang, L., Yang, C., Peng, Y., Liu, M., Wei, N., Fan, X., Yang, B., Jia, J., Chen, Y., Feng, J., et al. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103811 · Cited by 27
Xu, S., Zhang, H., Liu, T., Wang, Z., Yang, W., Hou, T., Wang, X., He, D., & Zheng, P. (2020) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22609 · Cited by 27
VGLL1 phosphorylation and activation promotes gastric cancer malignancy via TGF-β/ERK/RSK2 signaling
Im, J., Kim, D.-M., Park, H., Kang, M., Kim, D.-Y., Chang, K. Y., Kim, B., & Won, M. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2020.118892 · Cited by 27
Self-citationNeuronal TRPV1-CGRP axis regulates bone defect repair through Hippo signaling pathway
Jiang, Y., Zhu, Z., Wang, B., Yuan, Y., Zhang, Q., Li, Y., Du, Y., & Gong, P. (2023) · Cellular Signalling · doi:10.1016/j.cellsig.2023.110779 · Cited by 27
Metformin and Niclosamide Synergistically Suppress Wnt and YAP in APC-Mutated Colorectal Cancer
Kang, H. E., Seo, Y., Yun, J. S., Song, S. H., Han, D., Cho, E. S., Cho, S. B., Jeon, Y., Lee, H., Kim, H. S., et al. (2021) · Cancers · doi:10.3390/cancers13143437 · Cited by 27
Yorkie Growth-Promoting Activity Is Limited by Atg1-Mediated Phosphorylation
Tyra, L. K., Nandi, N., Tracy, C., & Krämer, H. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.01.011 · Cited by 26
YAP maintains the dynamics of TDP-43 condensates and antagonizes TDP-43 pathological aggregates
Zhang, J., Hu, J., Liu, R., Zhou, T., Luo, X., Liang, P., Xie, Z., Zhao, Q., Chen, Y., Du, D., et al. (2025) · Nature Cell Biology · doi:10.1038/s41556-025-01685-y · Cited by 26
Regulation of sensitivity of tumor cells to antitubulin drugs by Cdk1-TAZ signalling
Zhao, Y., & Yang, X. (2015) · Oncotarget · doi:10.18632/oncotarget.4259 · Cited by 26
Metadata
- Authors
- Mo, J.-S., Meng, Z., Kim, Y. C., Park, H. W., Hansen, C. G., Kim, S., Lim, D.-S., & Guan, K.-L.
- Affiliations
- University of California San Diego (US)
- Veterans Medical Research Foundation of San Diego (US)
- Korea Advanced Institute of Science and Technology (KR)
- Corresponding author
- Guan, Kun-Liang
- ORCID
- Venue
- Nature Cell Biology
- Published
- 2015-03-09
- Volume
- 17
- Issue
- 4
- Pages
- 500-510
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- PMC
- PMC4380774
- OpenAlex
- W1999661963
- Cited by
- 557
- References
- 51
- Citations by year
- 2026: 39 · 2025: 42 · 2024: 54 · 2023: 54 · 2022: 55 · 2021: 48 · 2020: 72 · 2019: 43 · 2018: 53 · 2017: 39 · 2016: 38 · 2015: 20
- FWCI
- 26.61
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Eye Institute (R01EY022611, EY022611)
- National Cancer Institute (CA 23100, CA132809, R01CA132809, P30CA023100)
- National Institute of Dental and Craniofacial Research (DE015964, R01DE015964)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- YAP, Hippo signaling pathway, AMPK, LATS kinase, YAP phosphorylation, TEAD transcription factors, oncogenic transformation, tumor suppression, glucose homeostasis, starvation
- MeSH terms
- Hippo Signaling Pathway, YAP-Signaling Proteins, TEA Domain Transcription Factors, Acyltransferases, Animals, Cell Line, Cell Transformation, Neoplastic, Cytoplasm, DNA-Binding Proteins, Energy Metabolism, Enzyme Activation, HeLa Cells, Humans, Mice, Nude, Nuclear Proteins, Phosphoproteins, Phosphorylation, Transcription Factors, Signal Transduction, 3T3 Cells, Protein Serine-Threonine Kinases, RNA Interference, RNA, Small Interfering, Adaptor Proteins, Signal Transducing, Mice, AMP-Activated Protein Kinases, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.